LCLetizia Ciliberti

Letizia Ciliberti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Letizia Ciliberti has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Omalizumab Is Associated With Successful Oral Immunotherapy After Failure in Severe Pediatric Food Allergy

    by Letizia Ciliberti, Simona Barni, Claudia Valleriani, Lucrezia Sarti, Giulia Liccioli, Leonardo Tomei, Gabriele Simonetti, Francesco Catamerò, Mattia Giovannini, R. Sharon Chinthrajah, et al.

  • Open Access

    Breast Milk and Allergic Disease Development: Immunological Factors Associated with Eczema, Food Allergy and Wheezing/Asthma

    by Alessandra Catalogna, Carlo Agostoni, Simona Barni, Roberto Berni Canani, Laura Carucci, Letizia Ciliberti, Serena Coppola, Antonio Corsello, Gregorio Paolo Milani, Francesca Mori, et al.

    Purpose of Review: Human milk (HM) contains a diverse array of immunological, microbial, and metabolic bioactive factors that may influence early immune maturation and allergic disease susceptibility. This narrative review examines current evidence linking major HM bioactives with eczema, food allergy, and wheezing/asthma, integrating mechanistic findings with human observational and clinical data. Recent Findings: Transforming growth factor-β (TGF-β), secretory IgA (sIgA), human milk oligosaccharides (HMOs), cytokines, fatty acids, short-chain fatty acids, the HM microbiome, and extracellular vesicles have all been implicated in pathways relevant to epithelial integrity, microbial colonization, and immune tolerance. However, associations with allergic outcomes are heterogeneous and frequently context dependent. Findings vary according to lactation stage, maternal characteristics, infant susceptibility, microbial exposures, and outcome definition. Mechanistic evidence is often stronger than prospective clinical evidence, and no individual HM component or bioactive profile has yet emerged as a reproducible predictor of allergy protection. Summary: Current evidence supports viewing HM as a dynamic maternal–milk–infant biological network rather than as a source of isolated protective factors. Future studies should integrate repeated HM sampling, rigorous allergic phenotyping, and multi-omic approaches to distinguish causal mediators from biomarkers of maternal or infant biology.

  • Elimination diet and formula choice in the management of food protein–induced allergic proctocolitis (FPIAP)

    by Simona Barni, Letizia Ciliberti, Lucrezia Sarti, Giulia Liccioli, Leonardo Tomei, Mattia Giovannini, Giulia Fissi, Francesco Catamerò, Francesca Mori


  • Open Access

    IgE-Mediated Legume Allergy in Children: Insights from a Single-Center Experience in Italy

    by Beatrice Serra, Simona Barni, Claudia Valleriani, Beatrice Coppadoro, Francesco Catamerò, Letizia Ciliberti, Mattia Giovannini, Giulia Liccioli, Lucrezia Sarti, Leonardo Tomei, et al.

    Background/Objectives: Legume allergy is increasingly recognized as plant-based diets expand and legume proteins are widely used in processed foods. We aimed to characterize the clinical features, sensitization profiles, and management outcomes of IgE-mediated legume allergy in Italian children. Methods: This retrospective single-center study (January 2022–January 2024) included children (p = 0.013) and liver transplantation (21% vs. 2%; p = 0.047). Peanut co-allergy occurred in 25.5%. Among 34 oral food challenges (OFCs), 23.5% were positive, including one case of pea-induced anaphylaxis. Of 16 oral immunotherapy (OIT) protocols initiated, 31.3% reached the full target maintenance dose, 37.5% remained on a lower, partial maintenance dose, and 31.3% were discontinued due to oral allergy syndrome (OAS). Conclusions: Pediatric legume allergy is characterized by early onset, frequent multi-legume involvement, and common co-allergies. In this cohort, pea allergy was associated with the highest proportion of severe reactions. Species-specific differences in severity, patterns of multi-legume involvement, and OIT outcomes should be interpreted cautiously given the limited sample size, while highlighting the need for tailored management and improved risk assessment across legume species.